Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact Dermatitis
- 1 June 2007
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 127 (6), 1419-1429
- https://doi.org/10.1038/sj.jid.5700717
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesProceedings of the National Academy of Sciences, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- CD28nullCD4+ T Cells – Characterization of an Effector Memory T‐Cell Population in Patients with Rheumatoid ArthritisScandinavian Journal of Immunology, 2004
- Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear lateBritish Journal of Dermatology, 2004
- Differential Voltage-dependent K+ Channel Responses during Proliferation and Activation in MacrophagesJournal of Biological Chemistry, 2003
- A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasisJournal of the American Academy of Dermatology, 2002
- Modulation of Kv Channel Expression and Function by TCR and Costimulatory Signals during Peripheral CD4+ Lymphocyte DifferentiationThe Journal of Experimental Medicine, 2002
- Local lymph node assay with non-radioisotope alternative endpoints.The Journal of Toxicological Sciences, 2002
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- CD4+ T-cell memory, CD45R subsets and the persistence of antigen—a unifying conceptImmunology Today, 1998